Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the ...

New research has mapped the cell types that specialize to form reproductive organs in both sexes, identifying key genes and ...

Coming up in the back half of December, the FDA will issue a verdict on Vanda Pharmaceuticals’ gastroparesis drug tradipitant ...

Fly this December and receive exclusive wildlife-themed amenity kits, highlighting endangered species with eco-friendly ...

Oregon parents and teachers form ICE watch groups using social media to alert communities about immigration enforcement near schools and neighborhoods.

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

The school sitcom has found new life on Netflix after being canceled not once but twice during its original run Ron Batzdorff/NBCU Photo Bank/NBCUniversal via Getty A.P. Bio may have been canceled two ...

Instil Bio, Inc. in-licensing brings on board high demand IMM2510 clinical product with PD-L1/VEGF targeting of solid tumors; proof-of-concept established by Summit/Akeso and BioNTech. Two competitive ...

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of ...

For many people interested in genome engineering, the era “before CRISPR” has faded into the deepest recesses of the mind, like a lost period of antiquity, even though it only entered the biotech ...